IS5304A - For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli - Google Patents

For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli

Info

Publication number: IS5304A
Authority: IS; Iceland
Prior art keywords: tocopherol; inhaled; liposome; powders stabilized; stabilized
Prior art date: 1997-06-27

Application number

IS5304A

Other languages

English (en)

Icelandic (is)

Inventor

Byström Katarina

Nilsson Per-Gunnar

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-27

Filing date

1999-12-15

Publication date

1999-12-15

1999-12-15 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1999-12-15 Publication of IS5304A publication Critical patent/IS5304A/is

Links

GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title 1
239000002502 liposome Substances 0.000 title 1
239000000843 powder Substances 0.000 title 1
229960001295 tocopherol Drugs 0.000 title 1
229930003799 tocopherol Natural products 0.000 title 1
235000010384 tocopherol Nutrition 0.000 title 1
239000011732 tocopherol Substances 0.000 title 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS5304A 1997-06-27 1999-12-15 For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli IS5304A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88441997A	1997-06-27	1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en)	1997-06-27	1998-06-08	Proliposome powders for inhalation stabilised by tocopherol

Publications (1)

Publication Number	Publication Date
IS5304A true IS5304A (is)	1999-12-15

Family

ID=25384589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5304A IS5304A (is)	1997-06-27	1999-12-15	For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli

Country Status (18)

Country	Link
EP (1)	EP1001749A1 (id)
JP (1)	JP2002510311A (id)
KR (1)	KR20010014163A (id)
CN (1)	CN1260713A (id)
AU (1)	AU729100B2 (id)
BR (1)	BR9810280A (id)
CA (1)	CA2295028A1 (id)
EE (1)	EE9900601A (id)
HU (1)	HUP0003207A3 (id)
ID (1)	ID23192A (id)
IL (1)	IL133478A0 (id)
IS (1)	IS5304A (id)
NO (1)	NO996439L (id)
NZ (1)	NZ501672A (id)
PL (1)	PL337723A1 (id)
SK (1)	SK184899A3 (id)
TR (1)	TR199903271T2 (id)
WO (1)	WO1999000111A1 (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (de) *	2000-03-28	2001-10-04	Primacare S.A.	Pro-liposomen
EP1138310A1 (de) *	2000-03-28	2001-10-04	Primacare S.A.	Pro-liposomen
EP1138313A1 (de) *	2000-03-28	2001-10-04	Primacare S.A.	Pro-liposomen
EP1888033B1 (en) *	2005-06-09	2014-02-19	Meda AB	Method and composition for treating inflammatory disorders
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
US20160073667A1 (en) *	2013-05-06	2016-03-17	Dsm Ip Assets B.V.	Powderous vitamin e formulation
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en)	2014-08-28	2017-08-31	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en)	2015-06-15	2016-12-15	Lipocine Inc.	Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) *	2015-09-29	2018-06-22	中山大学	α-生育酚在制备治疗血吸虫病药物中的应用
US11559530B2 (en)	2016-11-28	2023-01-24	Lipocine Inc.	Oral testosterone undecanoate therapy
EP3824296A4 (en)	2018-07-20	2022-04-27	Lipocine Inc.	LIVER DISEASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7908791A (en) *	1990-05-08	1991-11-27	Liposome Technology, Inc.	Direct spray-dried drug/lipid powder composition
SA95160463B1 (ar) *	1994-12-22	2005-10-04	استرا أكتيبولاج	مساحيق للاستنشاق

1998
- 1998-06-08 CA CA002295028A patent/CA2295028A1/en not_active Abandoned
- 1998-06-08 SK SK1848-99A patent/SK184899A3/sk unknown
- 1998-06-08 IL IL13347898A patent/IL133478A0/xx unknown
- 1998-06-08 EE EEP199900601A patent/EE9900601A/xx unknown
- 1998-06-08 HU HU0003207A patent/HUP0003207A3/hu unknown
- 1998-06-08 NZ NZ501672A patent/NZ501672A/en unknown
- 1998-06-08 CN CN98806377A patent/CN1260713A/zh active Pending
- 1998-06-08 AU AU79456/98A patent/AU729100B2/en not_active Ceased
- 1998-06-08 JP JP50548099A patent/JP2002510311A/ja active Pending
- 1998-06-08 KR KR1019997012234A patent/KR20010014163A/ko not_active Withdrawn
- 1998-06-08 WO PCT/SE1998/001090 patent/WO1999000111A1/en not_active Ceased
- 1998-06-08 PL PL98337723A patent/PL337723A1/xx unknown
- 1998-06-08 EP EP98929963A patent/EP1001749A1/en not_active Withdrawn
- 1998-06-08 TR TR1999/03271T patent/TR199903271T2/xx unknown
- 1998-06-08 BR BR9810280-0A patent/BR9810280A/pt not_active IP Right Cessation
- 1998-06-08 ID IDW991656A patent/ID23192A/id unknown
1999
- 1999-12-15 IS IS5304A patent/IS5304A/is unknown
- 1999-12-23 NO NO996439A patent/NO996439L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ID23192A (id)	2000-03-23
EP1001749A1 (en)	2000-05-24
IL133478A0 (en)	2001-04-30
NO996439L (no)	2000-02-28
AU729100B2 (en)	2001-01-25
NZ501672A (en)	2001-06-29
EE9900601A (et)	2000-08-15
HUP0003207A3 (en)	2001-03-28
TR199903271T2 (en)	2000-08-21
JP2002510311A (ja)	2002-04-02
KR20010014163A (ko)	2001-02-26
WO1999000111A1 (en)	1999-01-07
HUP0003207A2 (hu)	2001-02-28
SK184899A3 (en)	2000-05-16
CA2295028A1 (en)	1999-01-07
CN1260713A (zh)	2000-07-19
BR9810280A (pt)	2000-09-12
AU7945698A (en)	1999-01-19
PL337723A1 (en)	2000-08-28
NO996439D0 (no)	1999-12-23

Publication	Publication Date	Title
EE200400122A (et)	2005-02-15	Pulberinhalaator
NO990272L (no)	1999-03-22	Pulver-inhalator
DE69708327D1 (de)	2001-12-20	Pulverinhalator
ID24472A (id)	2000-07-20	Pembuatan aglomerat bubuk
IS5487A (is)	2000-05-11	Innúðatæki
ID18427A (id)	1998-04-09	Pengkabut serbuk
DE69841276D1 (de)	2009-12-17	Atemschutzmaske
FI942196A7 (fi)	1995-11-12	Jauheinhalaattori
NO2006014I1 (no)	2006-11-13	Insulin glulisin
DE69838271D1 (de)	2007-10-04	Verbesserte Atemschutzmaske
FI962520A7 (fi)	1996-06-17	Jauheinhalaattori
PL340284A1 (en)	2001-01-29	Modified polypeptides dependent on vitamin k
IS5878A (is)	2001-03-05	Lyfjagjöf á duftformi til lungna
IS5304A (is)	1999-12-15	For-lípósómdufttegundir til innöndunar gerðar stöðugri með tókóferóli
FI964595A7 (fi)	1996-11-15	Pulveri-inhalaattori
ATE281836T1 (de)	2004-11-15	Stabilisierte tibolone zubereitungen
FR2763507B1 (fr)	1999-07-02	Inhalateur
DE59909297D1 (de)	2004-06-03	Carbonyleisensilizid-Pulver
FI955441L (fi)	1997-05-11	Jauheinhalaattori
DE69824327D1 (de)	2004-07-15	Inhalationsgerät
DE69823490D1 (de)	2004-06-03	Antitranspirant präparat
NO20003182L (no)	2000-08-21	FremgangsmÕte for inhalering av pulverstoffer
DE69937138D1 (de)	2007-10-31	Verbundpulver
SE9703829D0 (sv)	1997-10-21	Powder inhaleri
DE59807895D1 (de)	2003-05-15	Pulverklarlack